Kamyar Kalantar-Zadeh M.D. to Polypharmacy
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Polypharmacy.
Connection Strength
0.972
-
Polypharmacy and Frailty among Hemodialysis Patients. Nephron. 2021; 145(6):624-632.
Score: 0.721
-
Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Sci Rep. 2020 11 03; 10(1):18964.
Score: 0.173
-
Frailty in patients on dialysis. Kidney Int. 2024 07; 106(1):35-49.
Score: 0.055
-
Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am J Hypertens. 2012 Mar; 25(3):379-88.
Score: 0.023